Log on / register
Feedback | Support | My details
How hyperglycemia promotes atherosclerosis: molecular mechanisms.
Aronson D, Rayfield EJ
Cardiovasc Diabetol 2002 Apr 8, 1:1
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
A structural model that explains the effects of hyperglycemia on collagenolysis.
Stultz CM, Edelman ER
Biophys J 2003 Oct, 85:2198-204
[PubMed Central] [PubMed] [Related articles]

2.
Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention.
Morgan KP, Kapur A, Beatt KJ
Heart 2004 Jul, 90:732-8
[PubMed Central] [PubMed] [Related articles]

3.
Phagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A.
Guest CB, Hartman ME, O'Connor JC, Chakour KS, Sovari AA, Freund GG
PLoS One 2007, 2:e511
[PubMed Central] [PubMed] [Related articles]

4.
PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN?
Chen J, Park HC, Patschan S, Brodsky SV, Gealikman O, Kuo MC, Li H, Addabbo F, Zhang F, Nasjletti A, Gross SS, Goligorsky MS
Drug Discov Today Ther Strateg 2007, 4:93-99
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 6 articles in BioMed Central

printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.